FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung CancerPRNewsWire • 05/28/21
Q1 Earnings Reveal Plenty Of Upside In Amgen, McDonald's And Colgate-PalmoliveSeeking Alpha • 05/21/21
New Tezepelumab Data Continue To Strengthen Profile For A Broad Population Of Severe Asthma PatientsPRNewsWire • 05/13/21
Efficacy Of Repatha® (Evolocumab) Across High-Risk Patient Populations Reinforced At ACC.21PRNewsWire • 05/11/21
Amgen To Present At The 2021 Bank of America Merrill Lynch Healthcare ConferencePRNewsWire • 05/06/21
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque PsoriasisPRNewsWire • 05/05/21
Is It Time to Buy the Dow Jones Industrials Average's 3 Worst-Performing Stocks of April?The Motley Fool • 05/05/21